MIT
CASSS

 

 

Poster Competition

The following abstracts have been accepted to compete in the 2014 BioMAN Summit's Poster Competition:

1.

Inhibitor mediated Bcr-Abl degradation: A novel therapeutic approach for Chronic Myeloid Leukemia

  Arifa Sayyidah Ahsan1, Marcus J. C. Long2, and Lizbeth Hedstrom3
  1Undergraduate Program in Biochemistry, Brandeis University
2Graduate Program in Biochemistry, Brandeis University
3Departments of Biology and Chemistry, Brandeis University
  View poster abstract
   
2. In-process Virus Tests as Forward Processing Decision Tool Enhance Containment of Virus Contaminations in Cell Culture Based Biomanufacturing
  Paul W. Barone1*, James C. Leung1*, Stacy Springs1*, and Michael E. Wiebe1*
 

1Center for Biomedical Innovation, Massachusetts Institute of Technology

*Equal contribution first authors

  View poster abstract
   
3. A Pharmacokinetic Model of a Tissue Implantable Insulin Sensor
  Gili Bisker1, Nicole M. Iverson2, Jiyoung Ahn1, and Michael S. Strano1
  1Department of Chemical Engineering, Massachusetts Institute of Technology
2Department of Biological Engineering, Massachusetts Institute of Technology
  View poster abstract
   
4. Rational design of peptides for affinity purification of biologics
  Divya Chandra1*, Steve Timmick1*, Chaz Goodwine1, Divya Shastry2, Steven Cramer1, and Pankaj Karande1
  1Howard P. Isermann Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute
2Department of Biochemistry and Biophysics, Rensselaer Polytechnic Institute
*Equal contribution first authors
  View poster abstract
   
5. Size-Based Biomolecule Preconcentration and Separation Using Slanted Nanofilter Array
  Sung Hee Ko1 and Jongyoon Han1,2,3
  1Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology
2Department of Biological Engineering, Massachusetts Institute of Technology
3BioSystems and Micromechanics (BioSyM) IRG, Singapore-MIT Alliance for Research and Technology (SMART) Centre, Singapore
  View poster abstract
   
6. UPLC-MS/MS analysis of glycoprotein changes in Mouse kidney cells with the phenotype of autosomal dominant polycystic kidney disease
  Yan-Jun Liu1, Anna Fan Zhang1, Shiaw-Lin Wu1, Yunjoon Jung2, Shan Qin2, William S. Hancock1, and Jordan A. Kreidberg2,3
  1Barnett Institute and Department of Chemistry and Chemical Biology, Northeastern University
2Department of Medicine, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School
3Harvard Stem Cell Institute, Harvard University
  View poster abstract
   
7. Tunable Staged Release of Therapeutics from Layer-By-Layer Coating with Clay Interlayer Barrier
  Jouha Min1,2, Richard D. Braatz1, and Paula T. Hammond1,2
  1Department of Chemical Engineering, Massachusetts Institute of Technology
2David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  View poster abstract
   
8. Protein quality testing by a microfluidic electrokinetic preconcentrator
  Wei Ouyang1, Sunghee Ko1, and Jongyoon Han1,2
  1Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology
2Department of Biological Engineering, Massachusetts Institute of Technology
  View poster abstract
   
9. Chemistry, Analysis and Biology of Protein Modifications: Methylation and Isoaspartic Acid
  Wanlu Qu1, Min Liu1, Bobby Lee1, and Zhaohui Sunny Zhou1
  1Barnett Institute of Chemical and Biological Analysis, Department of Chemistry and Chemical Biology, Northeastern University
  View poster abstract
   
10. Real time identification of therapeutics using Raman spectroscopy
  Gajendra P. Singh1, Ningren Han1, and Rajeev J. Ram1
  1Physical Optics and Electronics Group, Research Laboratory of Electronics, Massachusetts Institute of Technology
  View poster abstract
   
11. Spectroscopic approach for dynamic bioanalyte tracking with minimal concentration information
  Nicolas Spegazzini1, Ishan Barman2, and Ramachandra R. Dasari1
  1Laser Biomedical Research Center, Massachusetts Institute of Technology
2Department of Mechanical Engineering, Johns Hopkins University, Baltimore
  View poster abstract
   
12. Komagataella Phaffii Pastoris Host Cell Protein Characterization
  KyOnese Taylor1, Jared Auclair1, and William Hancock1
  1Barnett Institute and Department of Chemistry and Chemical Biology, Northeastern University
  View poster abstract
   
13. Integrated and Scalable Cyto-Technology (InSCyT) Platform for Monitoring two-chain Form of Biopharmaceutical Manufactured Recombinant Human Growth Hormone using LC-MS
  Annie Yu Wang1, Shiaw-Lin Wu1, and William S. Hancock1
  1Barnett Institute and Department of Chemistry and Chemical Biology, Northeastern University
  View poster abstract
   
14. Harnessing Amino Acids Mass Balance for Screening Mammalian Cell Lines with Recombinant Proteins as Products
  Wen Wang1 and Daniel I. C. Wang1
  1Department of Chemical Engineering, Massachusetts Institute of Technology
  View poster abstract
   
15. Analysis of Intact Recombinant Human Growth Hormone (rhGH) by Collision Induced Dissociation (CID) FTMS
  Di Wu1, Yang Tang1, Shaw-Lin Wu1, Jeff Agar1, and William Hancock1
  1Barnett Institute and Dept. of Chemistry and Chemical Biology, Northeastern University
  View poster abstract
   
16. Cooperative Co-culture of E. coli and S. cerevisiae for Overproduction of Paclitaxel Precursors
  Kang Zhou1, Kangjian Qiao1, Steven Edgar1, Gregory Stephanopoulos1
  1Department of Chemical Engineering, Massachusetts Institute of Technology
  View poster abstract
   

CASSS

Three poster prizes: 
1st place will receive $1000 (plus travel grant*);
2nd place will receive $500 (plus travel grant*), 
3rd place will receive a travel grant*.
*Travel grants include $1000 travel reimbursement and waived registration
to a CASSS-sponsored meeting (i.e. WCBP 2015 in Washington, DC)
.

Researchers will have an excellent opportunity to interact with a broad spectrum of biopharmaceutical manufacturers and vendors involved in research, development and manufacturing of biopharmaceuticals, including: Aastrom Biosciences, Alnylam Pharmaceuticals, Amgen, Biogen Idec, BioMarin, EMD Millipore, GE Healthcare, Genzyme, GlaxoSmithKline, MedImmune, Merck, Momenta Pharmaceuticals, Novartis, Sanofi, sanofi pasteur and Shire.

 
 
MIT CBI
BioMAN